Great Elm Group, Inc. (NASDAQ:GEG) Q1 2023 Earnings Conference Call November 15, 2022 9:00 AM ET Company Participants Adam Yates - Managing Director Peter Reed - Chief Executive Officer Adam Kleinman - President Brent Pearson - Chief Financial Officer Conference Call Participants Operator Good morning. My name is Chris and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Great Elm Group Fiscal 2023 First Quarter Conference Call. [Operator Instructions] Adam Yates, Ma ...

Great Elm Group, Inc. (NASDAQ:GEG) Q4 2022 Results Conference Call September 12, 2022 9:00 AM ET Company Participants Adam Yates - Managing Director Peter Reed - Chief Executive Officer Adam Kleinman - President Brent Pearson - CFO & CAO Conference Call Participants Brian Alexitch - Greenwich Investment Management Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Great Elm Group Fiscal 2022 Fourth Quarter Results Confer ...

Great Elm Group, Inc. (NASDAQ:GEG) Q2 2022 Earnings Conference Call February 11, 2022 9:00 AM ET Company Participants Adam Yates - Managing Director Peter Reed - Chief Executive Officer Brent Pearson - CFO & CAO Conference Call Participants Brian Alexitch - Greenwich Investment Management Operator Good morning. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Great Elm Group Second Quarter 2022 Financial Results. All lines have been placed on mu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39832 Great Elm Group, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpora ...

Financial Data and Key Metrics Changes - For the fiscal fourth quarter, consolidated revenue was $16.3 million, a decrease from $14.7 million in the same period last year, with a net loss from continuing operations of $1.4 million compared to a net income of $4.1 million last year [22][23] - Adjusted EBITDA for the fourth quarter was $3.5 million, down from $5.9 million in the prior year [22][23] - For the year ended June 30, 2021, total revenue increased to $57.6 million from $55.7 million, with adjusted EBITDA of $12.4 million compared to $16.0 million in the prior year [28][32] Business Line Data and Key Metrics Changes - Durable Medical Equipment (DME) generated $15.4 million in revenue for the fourth quarter, up from $13.9 million last year, driven by organic growth and acquisitions [25] - DME's total revenue for the year was $57.6 million, a 3.6% increase from the previous year, with net income rising to $5.9 million from $2.8 million [28][29] - Investment Management generated $0.9 million in revenue for the fourth quarter, slightly up from $0.7 million, with annual revenue of $3.2 million compared to $3.3 million in the prior year [32][33] Market Data and Key Metrics Changes - The DME business faced challenges due to the COVID-19 pandemic, with soft demand for sleep studies impacting referrals for new equipment setups [25] - The investment management segment benefited from a shared service agreement with Imperial Capital, enhancing the investment team's depth and experience [19] Company Strategy and Development Direction - The company aims to create shareholder value through its two verticals: operating companies and investment management, with a focus on acquisitions and increasing assets under management [5][10] - A transformative financing with JPMorgan has improved DME's cost of capital and provided funds for future acquisitions [12] - The company has simplified its corporate structure, reducing debt by $57 million and improving financial flexibility for growth opportunities [11][43] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about growth opportunities in the DME sector as the industry consolidates, despite current supply chain challenges [18][27] - The investment management segment is making strong progress in increasing assets under management and revenues, with a focus on proprietary investments and specialty finance [15][19] Other Important Information - The company completed a significant recapitalization of GECC, raising $31.7 million in a rights offering and closing a new $25 million revolving credit facility [14] - The company sold its entire ownership interest in two Class A office buildings for $4.6 million, reinvesting the proceeds into dividend-paying shares [17][18] Q&A Session Summary Question: What is the outlook for the DME business? - Management indicated that there are compelling opportunities in the DME sector as the industry continues to consolidate, despite current challenges [18] Question: How is the investment management segment performing? - The investment management segment is making strong progress in increasing assets under management and revenues, benefiting from strategic partnerships [19]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39832 GREAT ELM GROUP, INC. (Exact name of Registrant as specified in its charter) Delaware 85-3622015 (State or other jurisdiction of in ...

PART I. FINANCIAL INFORMATION [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The company's unaudited statements show total assets of $215.3 million and a nine-month net loss of $7.7 million Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | March 31, 2021 | June 30, 2020 | | :--- | :--- | :--- | | **Total Assets** | **$215,257** | **$195,445** | | Total Current Assets | $83,284 | $61,328 | | Goodwill | $50,658 | $50,010 | | **Total Liabilities** | **$148,338** | **$126,875** | | Total Current Liabilities | $35,464 | $25,514 | | Convertible notes | $21,036 | $17,444 | | **Total Stockholders' Equity** | **$64,864** | **$64,680** | Condensed Consolidated Statements of Operations Highlights (in thousands) | Metric | Three Months Ended Mar 31, 2021 | Three Months Ended Mar 31, 2020 | Nine Months Ended Mar 31, 2021 | Nine Months Ended Mar 31, 2020 | | :--- | :--- | :--- | :--- | :--- | | Total Revenues | $15,121 | $16,236 | $48,355 | $48,158 | | Operating Loss | $(379) | $(1,009) | $(2,013) | $(2,153) | | Net Loss | $(2,918) | $(11,918) | $(7,727) | $(17,223) | | Net Loss Attributable to GEG | $(2,760) | $(11,617) | $(6,865) | $(16,547) | | Diluted EPS | $(0.11) | $(0.46) | $(0.27) | $(0.65) | Condensed Consolidated Statements of Cash Flows Highlights (in thousands) | Cash Flow Activity | Nine Months Ended March 31, 2021 | Nine Months Ended March 31, 2020 | | :--- | :--- | :--- | | Net cash (used in) provided by operating activities | $(21,164) | $4,584 | | Net cash used in investing activities | $(13,361) | $(4,544) | | Net cash provided by financing activities | $18,465 | $26,660 | | **Net (decrease) increase in cash** | **$(16,060)** | **$26,700** | [Notes to Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Key disclosures include a corporate reorganization, a $37.7 million financing, and a $2.5 million CARES Act credit - On December 29, 2020, the company completed a reorganization, making **Great Elm Group, Inc. (GEG) the new public holding company**[24](index=24&type=chunk)[72](index=72&type=chunk) - The company operates in three segments: **durable medical equipment, investment management, and real estate**[24](index=24&type=chunk)[32](index=32&type=chunk) - On March 1, 2021, the company acquired Advanced Medical DME, LLC and PM Sleep Lab, LLC (AMPM) for a total consideration of **$1.1 million**[69](index=69&type=chunk)[70](index=70&type=chunk) - Following the reorganization, J.P. Morgan provided **$37.7 million in financing** through the issuance of preferred stock by a subsidiary[74](index=74&type=chunk)[78](index=78&type=chunk) - During the quarter ended March 31, 2021, the company claimed **$2.5 million in Employee Retention Credits (ERC)** under the expanded CARES Act[152](index=152&type=chunk) Revenue by Source (Nine Months Ended March 31, 2021, in thousands) | Revenue Source | 2021 | 2020 | | :--- | :--- | :--- | | **Durable Medical Equipment** | | | | Equipment Sales & Services | $27,363 | $25,725 | | Medical Equipment Rental | $14,907 | $16,028 | | **Investment Management** | $2,261 | $2,585 | | **Real Estate Rental** | $3,824 | $3,820 | | **Total Revenue** | **$48,355** | **$48,158** | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=43&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses segment performance, a major reorganization, and the ongoing impact of COVID-19 on operations - The company operates through three segments: durable medical equipment, investment management (**AUM of $245.7M** at March 31, 2021), and real estate[194](index=194&type=chunk)[196](index=196&type=chunk)[197](index=197&type=chunk) - The COVID-19 pandemic has continued to **suppress revenues**, particularly impacting the DME business's referral pipeline and investment management AUM[203](index=203&type=chunk) - A major corporate reorganization was completed on Dec 29, 2020, establishing GEG as the new holding company, followed by a **$37.7 million financing transaction with J.P. Morgan**[200](index=200&type=chunk)[201](index=201&type=chunk) - As of March 31, 2021, the company had **$24.3 million in unrestricted cash** and held 5,539,724 shares of GECC common stock valued at $18.8 million[267](index=267&type=chunk) Consolidated Operations Summary (Three Months Ended March 31, in thousands) | Metric | 2021 | 2020 | % Change | | :--- | :--- | :--- | :--- | | Total Revenue | $15,121 | $16,236 | (7)% | | Total Operating Expenses | $(15,500) | $(17,245) | (10)% | | Operating Loss | $(379) | $(1,009) | (62)% | | Pre-tax Loss | $(2,961) | $(12,066) | (75)% | [Results of Operations by Segment](index=47&type=section&id=Results%20of%20Operations%20by%20Segment) The DME segment's revenue declined 7% while the General Corporate segment's income improved significantly - **Durable Medical Equipment:** Revenue for Q1 2021 **decreased 7% YoY to $13.1 million** due to reduced new patient set-ups from the pandemic[220](index=220&type=chunk)[221](index=221&type=chunk)[223](index=223&type=chunk) - **Investment Management:** Revenue for Q1 2021 **decreased 11% YoY to $0.7 million**, primarily due to lower average assets under management[237](index=237&type=chunk)[239](index=239&type=chunk) - **Real Estate:** The segment demonstrated stability, with revenues and costs remaining consistent YoY at **$1.3 million in Q1 2021 revenue**[246](index=246&type=chunk)[247](index=247&type=chunk) - **General Corporate:** Other income for Q1 2021 was **$5.6 million**, a significant improvement from a loss of $9.3 million in Q1 2020, driven by fair value adjustments[250](index=250&type=chunk)[257](index=257&type=chunk)[258](index=258&type=chunk) [Liquidity and Capital Resources](index=52&type=section&id=Liquidity%20and%20Capital%20Resources) Operating cash flow was negative $21.2 million, while financing activities provided $18.5 million from the JPM transaction - Cash used in operating activities for the nine months ended March 31, 2021 was **$21.2 million**, primarily due to a net loss and investment purchases[260](index=260&type=chunk) - Cash provided by financing activities was **$18.5 million**, mainly from the JPM Transactions ($37.7 million gross proceeds), offset by debt repayment[265](index=265&type=chunk) - As of March 31, 2021, the company had **$33.5 million in face value of 5.0% Convertible Notes** outstanding, due 2030[269](index=269&type=chunk) - The company's subsidiary, Forest, has **$35.0 million in 9.0% preferred stock** held by JPM, which is mandatorily redeemable in 2027[271](index=271&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=55&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports no material changes in market risks from its most recent annual report - There have been **no material changes in market risks** since the last Annual Report on Form 10-K for the fiscal year ended June 30, 2020[283](index=283&type=chunk) [Controls and Procedures](index=55&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective with no material changes in internal controls - The CEO and CFO concluded that as of March 31, 2021, the company's **disclosure controls and procedures were effective**[284](index=284&type=chunk) - **No material changes** occurred in the company's internal control over financial reporting during the quarter ended March 31, 2021[285](index=285&type=chunk) PART II. OTHER INFORMATION [Legal Proceedings](index=55&type=section&id=Item%201.%20Legal%20Proceedings) The company reports no new disclosable information regarding legal proceedings - **No changes** required to be disclosed[286](index=286&type=chunk) [Risk Factors](index=55&type=section&id=Item%201A.%20Risk%20Factors) No material changes are reported from the risk factors previously disclosed in the annual report - **No material changes** have occurred from the risk factors disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2020[287](index=287&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=56&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reports no unregistered sales of equity securities during the period - **None reported**[289](index=289&type=chunk) [Defaults Upon Senior Securities](index=56&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reports no defaults upon its senior securities - **None reported**[290](index=290&type=chunk) [Mine Safety Disclosures](index=56&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This section is not applicable as the company has no mine safety disclosures to report - **None reported**[291](index=291&type=chunk) [Other Information](index=56&type=section&id=Item%205.%20Other%20Information) The company reports no other material information for the period - **None reported**[292](index=292&type=chunk) [Exhibits](index=56&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed with the Form 10-Q, including agreements and certifications

Great Elm Group, Inc. (GEC) Q2 2021 Earnings Conference Call February 16, 2021 8:30 AM ET Company Participants Peter Reed - Chief Executive Officer Brent Pearson - Chief Financial Officer Operator Ladies and gentlemen, thank you for standing by. Welcome to the Great Elm Group Q2 2021 Conference Call and Webcast. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] And I would like to hand the conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 800 South Street, Suite 230, Waltham MA 02453 (Address of principal executive offices) (Zip Code) Delaware 85-3622015 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...

Great Elm Capital Group, Inc. (GEC) Q2 2020 Results Earnings Conference Call February 10, 2020 8:00 AM ET Company Participants Adam Yates - Portfolio Manager Peter Reed - CEO Adam Kleinman - President & COO Brent Pearson - CFO John Ehlinger - Portfolio Manager Conference Call Participants Operator Ladies and gentlemen, thank you for standing by and welcome to the Great Elm Capital Group, Inc. Second Quarter 2020 Financial Results Call. At this time, all participants are in listen-only mode. After the speake ...